Ireland· IE-PA-EU/1/00/150/011
Actos
A pioglitazone product containing pioglitazone, registered in Ireland by Takeda Pharma A/S. The same ATC class is registered in 18 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Pioglitazone is registered in 18 of 19 countries.
Countries holding a registration under ATC A10BG03 (pioglitazone), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Pioglitazone · ATC A10BG03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pioglitazone costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.11 in United States to $1.64 in Switzerland — a ×14 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Pioglitazone · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.64
- ES Spain$1.22
- IT Italy$0.81
- US United States$0.11 (acquisition cost)
The record
At a glance
HPRA (Ireland)- Active substance
- Pioglitazone
- Manufacturer
- Takeda Pharma A/S
- Country
- Ireland (IE)
- ATC code
- A10BG03
- ATC class
- Pioglitazone
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/00/150/011
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
732 interactions on record for pioglitazone.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pioglitazone · interactions on record
732 records
- 11 severe
- 302 moderate
- 63 minor
- 355 info
Most severe, free to view
- ClopidogrelB01AC04severe
- GemfibrozilC10AB04severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pioglitazone in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaACTOSCHEPLAPHARM Arzneimittel GmbH, Greifswald
- United KingdomActos 15mg tabletsSigma Pharmaceuticals Plc
- United StatesActosTakeda Pharmaceuticals America, Inc.
- FinlandActosOrifarm Oy
- SpainACTOS 15 mg COMPRIMIDOSCheplapharm Arzneimittel Gmbh
- BelgiumActos 15 mgCheplapharm Arzneimittel
- SwedenActos 15 mg TablettCheplapharm Arzneimittel GmbH
- NetherlandsActos 15 mg tablet, tablettenCHEPLAPHARM Arzneimittel GmbH
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Bulgaria · Pioglitazone Sanovel, Пизона
- Cyprus · Zipion
- Czechia · Novapio, Pioglitazon Viatris
- Germany · Pioglitazon Aurobindo
- Spain · Pioglitazona Aurovitas, Pioglitazona Cinfa
- United Kingdom (Northern Ireland) · Pioglitazone Brown And Burk Uk Ltd, Pioglitazone Generics
- Greece · Glitact, Raglitan
- Croatia · Novapio, Pioglitazon Pliva
- Iceland · Actos, Pioglitazone Accord
- Italy · Pioglitazone Aurobindo, Pioglitazone Doc Generici
- Liechtenstein · Actos, Pioglitazone Accord
- Latvia · Zipion
- Malta · Novapio
- Netherlands · Pioglitazone Hydrochloride Aurobindo, Pioglitazone Sanovel
- Norway · Actos, Pioglitazone Accord
- Poland · Pioglitazone Bioton
- Portugal · Pioglitazona Atrolex, Pioglitazona Aurovitas
- Sweden · Pioglitazone Holsten
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1af64d74-1bfa-4d67-ac2d-cfbfc2f70539 GET /v1/drugs/1af64d74-1bfa-4d67-ac2d-cfbfc2f70539?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"A10BG03"
],
"strength": null,
"pa_number": "EU/1/00/150/011",
"substances": [
"Pioglitazone"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "16/09/2003",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about pioglitazone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.